Atlas Trials

Effect of Intravenous Nalbuphine on Emergence Agitation

Clinical trial NCT03470077 · COMPLETED

Trial details

NCT number
NCT03470077
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postoperative Complications
Start date
2019-07-31
Primary completion
2020-09-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.